Update in Internal Medicine 2025 (RP2505A)

Dallas, TX US
May 3, 2025

Overview

The knowledge and treatment of various disease states in internal medicine is expanding at a fast pace. Every year, new therapies are being developed, and new standards of care are employed across the spectrum of internal medicine. The busy primary care physician and internist, since they treat patients with varied diseases and comorbidities, are faced with the growing challenge of keeping abreast of the latest advances. The annual Update in Internal Medicine CME Conference seeks to assist clinicians in meeting this challenge. Our 2025 conference will feature didactic lectures, panel discussion, and interactive Q&A sessions, presented as a hybrid learning approach, offering the combination of a one-day live in-person presentation and pre-recorded on-demand presentations. The overall goal is to provide primary care physicians and internists with state-of-the-art practical advice on issues identified as frequent items for consultation and second opinions, as well as new advances in applying new scientific techniques and technologies in translational medicine.

HOW DO I REGISTER?

Click on the "REGISTER" tab, choose the appropriate category, and pay the registration fee.

Registration Type  UTSW Faculty and Staff Registration Non UTSW Attendee Registration 
Physician (MD/DO)$199$299
Advance Practice Provider (PA/NP)$199$299
Nurse$199$299
Physical Therapist$199$299
Other Healthcare Professional$199$299
Fellows, Residents, Medical Students$199$299

*Please select "Non UTSW Attendee" if you are NOT Faculty/Staff at UTSW Medical Cente

Target Audience

This course is designed for physicians, advanced practice providers, nurses, and physical therapists in the specialty of Internal Medicine, Family Practice, and Surgery. 

Learning Objectives

  • Identify the role of cardiac CT angiography in the evaluation and diagnosis of patients presenting with chest pain.
  • Develop an evidence-based approach to diagnosing and managing common mental health conditions in the primary care setting
  • Implement an evidence-based and collaborative approach to the diagnosis and treatment of musculoskeletal infections, including diabetes-related foot infections, by coordinating care with podiatrists, infectious disease specialists, and endocrinologists
  • Describe the expanding indications for GLP-1 agonist medications in the management of metabolic conditions.
  • Develop a systematic approach to the diagnosis and management of hypercalcemia and hypocalcemia to improve clinical outcomes.
  • Identify the indications for non-invasive and invasive ventilation strategies in the management of chronic respiratory failure.
  • Evaluate and interpret serologic and viral test results to accurately diagnose the causes of acute and chronic hepatitis.
  • Identify specific examples of low-value tests and treatments in internal medicine that can be de-implemented based on current evidence and best practices.
  • Develop a structured approach for the appropriate use of medical therapies and referral criteria for catheter ablation in the management of atrial fibrillation.
  • Identify the appropriate indications for low-dose CT lung cancer screening in high-risk patients and understand the clinical criteria for patient selection.

Additional Information

AttachmentSize
PDF icon Agenda_Upate in Internal Medicine 2025.pdf231.09 KB
Course summary
Available credit: 
  • 15.50 AMA
  • 15.50 Attendance
Course opens: 
12/13/2024
Course expires: 
05/02/2026
Event starts: 
05/03/2025 - 7:45am CDT
Event ends: 
05/03/2025 - 4:00pm CDT
Cost:
$299.00
Rating: 
0

Venue

UT Southwestern Medical Center T. Boone Pickens Auditorium (NG3.112 - North Campus)
6001 Forest Park Rd. Dallas, TX 75235
Dallas, TX 75235
United States

Faculty

Course Director(s)

James Cutrell, MD

has a financial relationship (Professional Services) with MDC/Deepull;.

Vlad Zaha, MD, PhD

has no relevant financial relationships to disclose at this time.
Peer reviewer(s)

James Cutrell, MD

has a financial relationship (Professional Services) with MDC/Deepull;.

Vlad Zaha, MD, PhD

has no relevant financial relationships to disclose at this time.
Speaker(s)

Gloria Ayuba, DO, FACC, FASE

has no relevant financial relationships to disclose at this time.

Natalie Bavli, M.D.

has no relevant financial relationships to disclose at this time.

Luigino Bernabela, MD, RhMSUS

has no relevant financial relationships to disclose at this time.

Sheena Bhalla

has a financial relationship (Independent contractor) with Mirati;.
has a financial relationship (Independent contractor) with Merus;.
has a financial relationship (Independent contractor) with AstraZeneca ;.

Timothy Brown, MD MSCE

has no relevant financial relationships to disclose at this time.

Leah Cohen, M.D.

has no relevant financial relationships to disclose at this time.

Suzanne Conzen

has a financial relationship (Patent) with Corcept Therapeutics;.

Kevin Courtney, MD, PhD

has a financial relationship (Patent) with Athena Diagnostics;.
has a financial relationship (Independent contractor) with Novartis;.

Sandeep Das, MD, MPH, MBA

has no relevant financial relationships to disclose at this time.

Luke Engelking, MD, PhD

has no relevant financial relationships to disclose at this time.

Elizabeth Hardin, MD

has no relevant financial relationships to disclose at this time.

Arthur Hong, MD, MPH

has no relevant financial relationships to disclose at this time.

Emily Kahl

has no relevant financial relationships to disclose at this time.

Thomas Kerr, M.D./Ph.D.

has a financial relationship (Grant Or Contract) with Alexion;.
has a financial relationship (Independent contractor) with Alexion;.
has a financial relationship (Independent contractor) with UpToDate;.

Siddharth Kogilwaimath

has no relevant financial relationships to disclose at this time.

Xiao-Fei Kong, M.D, Ph.D

has no relevant financial relationships to disclose at this time.

Paul Lederer

has no relevant financial relationships to disclose at this time.

Bethany Lussier, MD

has a financial relationship (Professional Services) with Biogen;.

Joseph Merola, Professor

has a financial relationship (Professional Services) with Amgen;.
has a financial relationship (Professional Services) with Eli Lilly;.
has a financial relationship (Professional Services) with UCB;.
has a financial relationship (Professional Services) with Bristol-Myers Squibb;.
has a financial relationship (Professional Services) with Janssen;.
has a financial relationship (Professional Services) with Boehringer Ingelheim;.
has a financial relationship (Professional Services) with Novartis;.
has a financial relationship (Professional Services) with Pfizer;.
has a financial relationship (Professional Services) with Abbvie;.
has a financial relationship (Professional Services) with Moonlake;.
has a financial relationship (Professional Services) with Sanofi-Regeneron;.

Orson Moe, MD

has a financial relationship (Professional Services) with Alnylum;.
has a financial relationship (Professional Services) with Tricida;.
has a financial relationship (Professional Services) with Allena Pharmaceutical;.
has a financial relationship (Professional Services) with Janssen;.
has a financial relationship (Professional Services) with Dicerna;.
has a financial relationship (Professional Services) with Applied Theraputics;.

Nimesh Patel, M.D.

has no relevant financial relationships to disclose at this time.

Anand Rohatgi, MD, MSCS

has a financial relationship (Financial Support) with JP Morgan;.
has a financial relationship (Financial Support) with CSL;.
has a financial relationship (Financial Support) with Johnson and Johnson;.
has a financial relationship (Financial Support) with Raydel;.
has a financial relationship (Financial Support) with Raydel;.
has a financial relationship (Financial Support) with Quest;.

Ramesh Saxena

has no relevant financial relationships to disclose at this time.

Taylor Schaubschlager, D.O.

has no relevant financial relationships to disclose at this time.

Joslyn Strebe

has no relevant financial relationships to disclose at this time.

Alexander Tatara, M.D., Ph.D.

has no relevant financial relationships to disclose at this time.

Anna Tavakkoli

has no relevant financial relationships to disclose at this time.

Alex Tessnow, MD, MBA

has a financial relationship (Independent contractor) with Abbvie;.
has a financial relationship (Independent contractor) with Horizon Pharmaceuticals;.

Miguel Vazquez, Miguel A. Vazquez, MD

has no relevant financial relationships to disclose at this time.

Tonia Vinton, MD

has a financial relationship (Grant Or Contract) with Eli Lilly;.

Christoph Zechner, MD, PhD

has no relevant financial relationships to disclose at this time.

Accreditation

The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statements

The University of Texas Southwestern Medical Center designates this live educational activity for a maximum of 15.5 AMA PRA Category1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Texas Southwestern Medical Center certifies that non-physicians will receive an attendance certificate stating that they participated in the activity that was designated for 15.5 AMA PRA Category 1 Credit™.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

Available Credit

  • 15.50 AMA
  • 15.50 Attendance

Register/Take course

Price

Cost:
$299.00
Please login or create an account to take this course.

To register:

  1. "Login" to your existing account or create an account in EthosCE, online learning management system, by selecting the "create an account" link.
  2. Once logged in, return to this course page, select the designated fee and click the "add to cart" button.
  3. In the following "checkout" pages you will verify and process your payment.
  4. After registration is completed, a confirmation will be sent by email.

A $25 handling fee will be deducted from cancellation refunds. Refund requests must be received by email at CEOffice@utsouthwestern.edu by April 16, 2025.  No refunds will be made thereafter.